Sambratha Shetty
Chief Operating Officer, Synergia Foundation
A clear picture of India’s drug discovery
India’s domestic pharmaceutical industry excels in the production of generic medicines but the rate of drug discovery is staggeringly below the global industry average. Drug discovery is an expensive, slow and risky business and most Indian companies do not have sufficient financial resources to take the risk to develop a new drug from scratch. Does India have the resources to become the pharmaceutical powerhouse, it aspires to be?
To read the full research paper, Subscribe.
HE M.K. Narayanan
Former National Security Adviser, GOI
The Emerging World Order
Maj. Gen. Moni Chandi (Retd.)
Chief Strategic Officer, Synergia Foundation
Resolution to the Kashmir conflict
Hon Sec Michael Chertoff
Fmr Sec U.S. Homeland Security
Dark Web and Internet Governance
Maj. Gen. Moni Chandi (Retd.)
Chief Strategic Officer, Synergia Foundation
China's Belt & Road Initiative
